Acadia Pharmaceuticals Inc – IPO: ‘S-1’ on 12/21/00 – EX-27.1

On:  Thursday, 12/21/00, at 5:28pm ET   ·   Accession #:  912057-0-54458   ·   File #:  333-52492

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Initial Public Offering (IPO):  Registration Statement (General Form)   —   Form S-1
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-1         Registration Statement (General Form)                115    557K 
 2: EX-3.1      Articles of Incorporation/Organization or By-Laws     25    105K 
 3: EX-3.2      Articles of Incorporation/Organization or By-Laws      5     25K 
 4: EX-3.3      Articles of Incorporation/Organization or By-Laws     15     75K 
 5: EX-3.4      Articles of Incorporation/Organization or By-Laws     28    132K 
 6: EX-4.1      Instrument Defining the Rights of Security Holders     2     11K 
 7: EX-4.2      Instrument Defining the Rights of Security Holders    43    201K 
 8: EX-4.3      Instrument Defining the Rights of Security Holders    13     55K 
 9: EX-10.1     Material Contract                                      6     28K 
18: EX-10.10    Material Contract                                      3     17K 
19: EX-10.11    Material Contract                                      3     20K 
20: EX-10.12    Material Contract                                      6     36K 
21: EX-10.13    Material Contract                                     27    104K 
22: EX-10.14    Material Contract                                     56    197K 
23: EX-10.15    Material Contract                                     51    186K 
24: EX-10.16    Material Contract                                     33    108K 
25: EX-10.17    Material Contract                                      3     18K 
26: EX-10.18    Material Contract                                     39    210K 
10: EX-10.2     Material Contract                                     19     75K 
11: EX-10.3     Material Contract                                     21     92K 
12: EX-10.4     Material Contract                                     17     71K 
13: EX-10.5     Material Contract                                     16     67K 
14: EX-10.6     Material Contract                                     55    282K 
15: EX-10.7     Material Contract                                      3     20K 
16: EX-10.8     Material Contract                                      9     45K 
17: EX-10.9     Material Contract                                      3     19K 
27: EX-23.1     Consent of Experts or Counsel                          1      9K 
28: EX-27.1     Financial Data Schedule (Pre-XBRL)                     2     11K 

EX-27.1   —   Financial Data Schedule (Pre-XBRL)

EX-27.1
1st Page of 2
TOC
↑Top
Previous
Next
↓Bottom
Just 1st
 
                                                                [Download Table]
                                                                                  

EX-27.1
Last Page of 2
TOC
1st
Previous
Next
↓Bottom
Just 2nd
<ARTICLE> 5                                                                       
<MULTIPLIER> 1,000                                                                
<CURRENCY> U.S. DOLLARS                                                           

                                                                                  
<PERIOD-TYPE>                YEAR              YEAR             9-MOS             
<FISCAL-YEAR-END>                  DEC-31-1998       DEC-31-1999       DEC-31-2000
<PERIOD-START>                     JAN-01-1998       JAN-01-1999       JAN-01-2000
<PERIOD-END>                       DEC-31-1998       DEC-31-1999       SEP-30-2000
<EXCHANGE-RATE>                              1                 1                 1
<CASH>                                   4,779             3,684            10,218
<SECURITIES>                            12,798             8,525            19,266
<RECEIVABLES>                              209                 0                 0
<ALLOWANCES>                                 0                 0                 0
<INVENTORY>                                  0                 0                 0
<CURRENT-ASSETS>                           599               438               633
<PP&E>                                   3,024             3,965             4,984
<DEPRECIATION>                             724             1,456             2,104
<TOTAL-ASSETS>                          21,063            15,518            33,471
<CURRENT-LIABILITIES>                    1,446             1,859             2,968
<BONDS>                                  3,367             4,432             4,632
<PREFERRED-MANDATORY>                   24,665            24,665            46,502
<PREFERRED>                                  0                 0                 0
<COMMON>                                     0                 0                 0
<OTHER-SE>                             (8,414)          (15,437)          (20,630)
<TOTAL-LIABILITY-AND-EQUITY>            21,063            15,518            33,471
<SALES>                                      0                 0                 0
<TOTAL-REVENUES>                         1,419             2,238             2,768
<CGS>                                        0                 0                 0
<TOTAL-COSTS>                                0                 0                 0
<OTHER-EXPENSES>                         8,343            10,083            11,242
<LOSS-PROVISION>                             0                 0                 0
<INTEREST-EXPENSE>                       (521)             (400)             (720)
<INCOME-PRETAX>                        (6,403)           (7,445)           (7,754)
<INCOME-TAX>                                 0                 0                 0
<INCOME-CONTINUING>                    (6,403)           (7,445)           (7,754)
<DISCONTINUED>                               0                 0                 0
<EXTRAORDINARY>                              0                 0                 0
<CHANGES>                                    0                 0                 0
<NET-INCOME>                           (6,403)           (7,445)           (7,754)
<EPS-BASIC>                             (3.12)            (3.57)            (3.63)
<EPS-DILUTED>                           (3.12)            (3.57)            (3.63)

20 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/28/24  Acadia Pharmaceuticals Inc.       10-K       12/31/23   88:14M                                    Donnelley … Solutions/FA
11/03/23  Acadia Pharmaceuticals Inc.       10-Q        9/30/23   63:8.1M                                   Donnelley … Solutions/FA
 8/03/23  Acadia Pharmaceuticals Inc.       10-Q        6/30/23   66:10M                                    Donnelley … Solutions/FA
 5/08/23  Acadia Pharmaceuticals Inc.       10-Q        3/31/23   59:7.7M                                   Donnelley … Solutions/FA
 2/28/23  Acadia Pharmaceuticals Inc.       10-K       12/31/22   79:15M                                    Donnelley … Solutions/FA
 2/07/23  Acadia Pharmaceuticals Inc.       S-8         2/07/23    7:268K                                   Donnelley … Solutions/FA
11/03/22  Acadia Pharmaceuticals Inc.       10-Q        9/30/22   60:9M                                     Donnelley … Solutions/FA
 8/09/22  Acadia Pharmaceuticals Inc.       S-8         8/09/22    5:190K                                   Donnelley … Solutions/FA
 8/09/22  Acadia Pharmaceuticals Inc.       10-Q        6/30/22   58:8.3M                                   Donnelley … Solutions/FA
 5/25/22  Acadia Pharmaceuticals Inc.       S-3ASR      5/25/22    4:265K                                   Donnelley … Solutions/FA
 5/05/22  Acadia Pharmaceuticals Inc.       10-Q        3/31/22   57:7.5M                                   Donnelley … Solutions/FA
 3/01/22  Acadia Pharmaceuticals Inc.       10-K       12/31/21   82:13M                                    Donnelley … Solutions/FA
11/09/21  Acadia Pharmaceuticals Inc.       10-Q        9/30/21   57:7.2M                                   ActiveDisclosure/FA
 8/05/21  Acadia Pharmaceuticals Inc.       10-Q        6/30/21   59:7.2M                                   ActiveDisclosure/FA
 5/06/21  Acadia Pharmaceuticals Inc.       10-Q        3/31/21   63:7.5M                                   ActiveDisclosure/FA
 2/25/21  Acadia Pharmaceuticals Inc.       10-K       12/31/20   80:13M                                    ActiveDisclosure/FA
11/04/20  Acadia Pharmaceuticals Inc.       10-Q        9/30/20   60:7.1M                                   ActiveDisclosure/FA
 8/25/20  Acadia Pharmaceuticals Inc.       S-3ASR      8/25/20    3:196K                                   Donnelley … Solutions/FA
 8/06/20  Acadia Pharmaceuticals Inc.       10-Q        6/30/20   57:6.9M                                   ActiveDisclosure/FA
 8/06/20  Acadia Pharmaceuticals Inc.       S-8         8/06/20    3:53K                                    Donnelley … Solutions/FA